Senti Biosciences Holdings SNTI Cash Flow Statement (2021-2026)

NASDAQ SNTI
$0.19 -0.03 (-12.41%)
At close: Oct 22, 2026 · 4:00 PM EDT
Reported Financials

Senti Biosciences Holdings Quarterly Cash Flow Statement

Periods 21 quarters
Latest Jun 2026

Senti Biosciences Holdings cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 21 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-12.01M-11.41M-10.90M-11.81M-11.55M-16.64M-58.21M-18.72M-18.70M-14.92M-71.06M-12.11M-11.20M-28.87M-0.60M-14.11M-14.73M-18.13M-14.44M-12.75M
Depreciation and DepletionDep. & Depletion
0.20M0.20M0.26M0.24M0.30M0.40M0.45M0.47M0.80M1.35M0.99M0.98M0.97M0.95M0.94M0.93M0.91M0.90M0.89M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.20M0.20M0.26M0.24M0.30M0.40M0.45M0.47M0.80M1.35M0.99M0.98M0.97M0.95M0.94M0.93M0.91M0.90M0.89M
Share-based CompensationStock Comp.
0.63M0.74M0.66M9.23M2.29M4.22M3.76M3.43M0.41M2.06M1.26M-0.78M0.67M0.61M1.20M1.53M1.55M1.43M
Gains from Sales and DivestituresGains Divest
-0.01M-0.01M-0.01M0.00M0.01M21.86M-0.04M0.11M
Asset Writedowns and ImpairmentWritedown
25.69M0.26M0.30M5.10M
Other non-cash itemsOther Non-Cash
0.81M0.77M-10.17M0.10M-0.23M0.40M-0.15M0.48M0.48M-1.51M-0.27M
Change in Working Capital
Change in ReceivablesChange Receivables
0.05M-0.05M0.14M0.27M-0.23M0.14M-0.20M2.16M-1.16M-0.06M0.13M0.02M0.62M0.41M1.47M-1.95M-0.15M
Change in Account PayablesChange Payables
0.00M0.81M-2.33M-0.16M0.40M-0.14M0.09M0.28M0.61M-0.42M-0.76M0.39M-0.44M-0.39M1.24M0.36M-0.54M0.75M1.17M
Change in Accured ExpensesChange Accured Exp.
0.00M1.77M0.16M-1.41M1.62M1.29M0.57M-1.85M-0.24M0.89M1.91M-2.95M-0.17M0.42M2.03M-1.12M-0.05M1.48M0.25M
Change in Other Operating AssetsOther Assets Change
0.79M0.06M0.38M0.99M0.47M-0.54M0.40M-0.40M-1.45M-3.35M-0.48M-0.50M-0.52M-0.52M-0.54M-0.56M-0.58M-0.61M
Change in Other Operating LiabilitiesOther Liabilities Change
0.05M-0.68M-0.56M1.97M4.98M2.48M3.67M0.49M-0.09M-1.09M0.37M-0.95M-0.98M-0.92M-1.18M-1.09M-1.13M-1.19M-1.19M
Other Working Capital ChangesOther WC Changes
-0.73M-0.68M-0.62M1.59M3.98M2.02M4.20M0.09M0.31M0.36M3.72M-0.47M-0.49M-0.40M-0.66M-0.55M-0.57M-0.61M-0.58M
Other Operating ActivitiesOther Ops.
-0.01M-0.03M0.03M-0.02M0.06M0.04M-0.04M0.01M0.11M
Cash from OperationsCash from Ops.
-0.93M-8.81M-11.97M-10.06M-5.70M-10.14M-9.01M-16.30M-13.68M-15.38M-7.04M-11.68M-8.35M-7.87M-13.50M-14.05M-13.07M-9.45M-6.88M
Investing Activities
Capital ExpendituresCapex
0.93M3.99M7.38M11.26M14.20M8.53M6.51M3.67M1.86M0.00M0.02M0.01M0.20M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.11M0.06M
Change in Property, Plant and EquipmentChange in PP&E
-0.93M-3.99M-7.38M-11.26M-14.20M-8.53M-6.51M-3.67M-1.86M0.10M-0.02M0.06M-0.01M-0.20M
Purchase of InvestmentsInvestments Purchased
230.00M40.59M17.99M
Sale and Maturity of InvestmentsInvestments Sold
15.00M22.00M23.00M
Cash from Investing ActivitiesCash from Investing
-230.00M-0.93M-3.99M-7.38M-11.26M-14.20M-49.12M-9.50M18.33M21.14M0.10M-0.02M0.06M-0.01M-0.18M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.25M
Long-Term Debt RepaymentsLT Debt Repayment
0.25M0.04M0.03M0.02M0.02M
Non-Current Debt
-0.04M-0.03M-0.02M-0.02M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.04M-0.03M-0.02M-0.02M
Change in Capital Stock
Common Stock IssuedStock Issued
232.56M0.01M0.02M0.14M112.85M-0.49M0.88M0.31M0.58M2.43M49.72M1.51M1.54M-0.53M0.53M
Net Shares Issued and RepurchasedNet Shares Issued
232.56M0.01M0.02M0.14M112.85M-0.49M0.88M0.31M0.58M2.43M49.72M1.51M1.54M-0.53M0.53M
Net Equity Issued and RepurchasedNet Equity Issued
232.56M0.01M0.02M0.14M112.85M-0.49M0.88M0.31M0.58M2.43M49.72M1.51M1.54M-0.53M0.53M
Other financing activitiesOther financing
-0.52M-0.60M0.60M-0.23M-1.92M-0.53M-0.01M
Cash from Financing ActivitiesCash from Financing
232.03M0.49M0.02M-0.46M118.62M-0.49M0.88M-0.04M0.28M-0.02M0.56M2.44M51.29M-0.41M1.01M0.12M11.04M
Additional items
Change in Cash
1.10M-9.25M-15.93M-17.89M101.66M-24.82M-57.25M-25.84M4.94M5.74M-6.38M-11.70M-8.35M-5.37M37.78M-14.46M-12.25M-9.32M4.17M
Ending Cash Balance
84.47M75.22M59.29M41.40M143.06M118.24M60.99M35.15M40.09M45.83M39.45M27.75M19.41M14.04M51.82M37.35M25.11M15.78M19.95M7.89M
Free Cash FlowFCF
-0.93M-9.74M-15.96M-17.44M-16.96M-24.34M-17.54M-22.81M-17.34M-17.24M-7.04M-11.70M-8.35M-7.87M-13.52M-14.05M-13.27M-9.45M-6.88M
Net Cash FlowNCF
1.10M-9.25M-15.93M-17.89M101.66M-24.82M-57.25M-25.84M4.94M5.74M-6.38M-11.70M-8.35M-5.37M37.78M-14.46M-12.25M-9.32M4.17M

Senti Biosciences Holdings Cash Flow Statement API

Pull Senti Biosciences Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SNTI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY